1887

Abstract

We have analysed the expression of transformation-associated viral antigens, the Epstein–Barr virus (EBV) DNA content and the phenotypic characteristics of two B95-8 virus-converted sublines of the EBV-negative Burkittʹs lymphoma (BL) line BL28. The converted lines called E95A-BL28 and E95B-BL28, respectively, differed in their EBV gene expression. The E95B convertant expressed virus-encoded nuclear antigens EBNA1 to -6 and the membrane protein LMP1, but only EBNA2 and EBNA5 were detected by immunofluorescence and immunoblotting in the E95A convertant. Only the entire HI W, Y and H regions could be detected in the E95A convertant by hybridization of Southern blots with probes covering the HI C, W, Y, H, F, E, K and Nhet regions of the EBV genome. EBV episomes were found to be absent in the E95A convertant as seen by Gardella gels. The E95A convertant retained the phenotypic characteristics of the EBV-negative parental line, and remained highly clonable in agarose. In contrast, expression of EBNA1 to -6 and LMP1 was accompanied by a shift towards a more lymphoblastoid cell line-like phenotype and by loss of agarose clonability in the E95B convertant.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-7-1393
1993-07-01
2021-10-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/7/JV0740071393.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-7-1393&mimeType=html&fmt=ahah

References

  1. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams A, Ziegler A. 1987; Production of a monoclonal antibodies to group A erythrocytes. HLA and other human cell surface antigens: new tools for genetic analysis.. Cell 14:9–20
    [Google Scholar]
  2. Clark EA, Ledbetter IA, Holly RC, Dinndorf PA, Shu G. 1986; Polypeptides on human B-lymphocytes associated with cell activation.. Human Immunology 16:100–113
    [Google Scholar]
  3. Colombani J, Dausett J, Lepage V, Degof L, Kalil J, Fellous M. 1982; HLA monoclonal registry; a proposal.. Tissue Antigens 20:161–171
    [Google Scholar]
  4. Dambaugh T, Wang F, Hennesy K, Woodland E, Rickinson A, Kieff E. 1986; Expression of the Epstein–Barr virus nuclear antigen 2 in rodent cells.. Journal of Virology 59:453–162
    [Google Scholar]
  5. Fahraeus R, Rymo L, Rhim JS, Klein G. 1990; Morphological transformation of human keratinocytes expressing the LMP gene of Epstein–Barr virus.. Nature, London 345:447–149
    [Google Scholar]
  6. Finke J, Rowe M, Kallin B, Ernberg I, Rosen A, Dillner J, Klein G. 1987; Monoclonal and polyclonal antibodies against Epstein–Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt’s lymphoma and lymphoblastoid cell lines.. Journal of Virology 61:3870–3878
    [Google Scholar]
  7. Gardella TP, Medveczky P, Sairenji T, Mulder C. 1984; Detection of circular and linear herpes virus DNA molecules in mammalian cells by gel electrophoresis.. Journal of Virology 50:248–254
    [Google Scholar]
  8. Gualandi G, Santolini E, Calef E. 1992; Epstein–Barr virus DNA recombines via latent origin of replication with the human genome in the lymphoblastoid cell line, RGN1.. Journal of Virology 66:5677–5681
    [Google Scholar]
  9. Hinuma Y, Grace JT. 1967; Cloning of immunoglobulin producing human leukemic and lymphoma cells in long term cultures.. Proceedings of the Society for Experimental Biology and Medicine 124:107–111
    [Google Scholar]
  10. Hurley E, Thorley-Lawson D. 1988; Cell activation and the establishment of Epstein–Barr virus latency.. Journal of Experimental Medicine 168:2059–2075
    [Google Scholar]
  11. Hurley E, Agger S, McNeil JA, Lawrence JB, Calendar A, Lenoir G, Thorley-Lawson D. 1991a; When Epstein–Barr virus persistently infects B-cell lines, it frequently integrates.. Journal of Virology 65:1245–1254
    [Google Scholar]
  12. Hurley EA, Klaman L, Agger S, Lawrence JB, Thorley-Lawson D. 1991b; The prototypical Epstein–Barr virus transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA.. Journal of Virology 65:3958–3963
    [Google Scholar]
  13. Jones MD, Foster L, Sheedy T, Griffin B. 1984; The EB virus genome in Daudi Burkitt lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR1) of the virus.. EMBO Journal 3:813–821
    [Google Scholar]
  14. Kieff E, Liebowitz D. 1989; The Epstein–Barr virus.. Virology 21889–1920Edited by Fields BN, Knipe DM. New York: Raven Press.;
    [Google Scholar]
  15. Klein G, Henriksson-Ehlin B, Schlossmann S. F. 1983; Induction of an activated B-lymphocyte associated surface moiety defined by the B2 monoclonal antibody by EBV conversion of an EBV negative lymphoma line (Ramos): differential effect of transforming (B95-8) and non-transforming (P3HR1) substrains.. Journal of Immunology 130:1985–1989
    [Google Scholar]
  16. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4.. Nature, London 227:680–685
    [Google Scholar]
  17. Lenoir G, Vuillaume M, Bonnardel C. 1985; The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt’s lymphoma.. In Burkitt’s Lymphoma: A Human Cancer Mode pp 309–318Edited by Lenoir G, Connor GO, Olweny CLM. Lyon: IARC.;
    [Google Scholar]
  18. Lindahl T, Klein G, Reedman BM, Johansson B, Singh S. 1974; Relationship between Epstein–Barr virus DNA and EBV determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies.. International Journal of Cancer 13:764–772
    [Google Scholar]
  19. Maniatis T, Fritsch EF, Sambrook J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory.;
    [Google Scholar]
  20. Mann KP, Staunton D, Thorley-Lawson DA. 1985; Epstein–Barr virus-encoded protein found in plasma membranes of transformed cells.. Journal of Virology 55:710–720
    [Google Scholar]
  21. Mannick J, Cohen J, Birkenbach M, Marchini A, Kieff E. 1991; The Epstein–Barr virus nuclear protein encoded by the leader of EBNA RNAs is important in B-lymphocyte transformation.. Journal of Virology 65:6826–6837
    [Google Scholar]
  22. Patarroyo M, Prieto J, Ernberg I, Gahmberg CG. 1988; Absence or low expression, of leukocyte adhesion molecules CD 11 and CD 18 on Burkitt’s lymphoma cells.. International Journal of Cancer 41:901–907
    [Google Scholar]
  23. Reedman BM, Klein G. 1973; Cellular localization of an Epstein–Barr virus (EBV)-associated complement fixing antigen in producer and non-producer lymphoblastoid cell lines.. International Journal of Cancer 11:499–520
    [Google Scholar]
  24. Ritz J, Pesando JM, Notis-McConarty J, Lazarus H, Schlossman SF. 1980; A monoclonal antibody to human acute lymphoblastic leukaemia antigen.. London 283:583–585
    [Google Scholar]
  25. Rowe M, Hilgreth JEK, Rickinson AB, Epstein MA. 1982; Monoclonal antibodies to Epstein–Barr virus-induced transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity.. International Journal of Cancer 29:373–381
    [Google Scholar]
  26. Rowe M, Rowe DT, Gregory C, Young LS, Farrell PJ, Rupani H, Rickinson AB. 1987; Differences in B-cell growth phenotype reflect a novel pattern of Epstein–Barr virus latent gene expression in Burkitt’s lymphoma cells.. EMBO Journal 6:2743–2752
    [Google Scholar]
  27. Torsteindottir S, Andersson ML, Avila-Carino J, Henriksson-Ehlin B, Masucci MG, Klein G, Klein E. 1989; Reversion of tumorigenicity and decreased agarose clon-ability after EBV conversion of an IgH/myc translocation carrying BL line.. International Journal of Cancer 43:273–278
    [Google Scholar]
  28. Towbin H, Staehelin T, Gordon J. 1976; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.. Proceedings of the National Academy of Sciences, U.S.A. 76:4350–4354
    [Google Scholar]
  29. Wang D, Leibowitz D, Kieff E. 1985; An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.. Cell 434:831–840
    [Google Scholar]
  30. Weils J, Fellous M, Tursz T. 1981; Monoclonal antibody against a Burkitt lymphoma associated antigen.. Proceedings of the National Academy of Sciences, U.S.A. 78:6485–6488
    [Google Scholar]
  31. Yates J, Warren N, Reisman D, Sugden B. 1984; A cis-acting element from the Epstein–Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.. Proceedings of the National Academy of Sciences, U.S.A. 81:3806–3810
    [Google Scholar]
  32. Young LS, Alfieri C, Hennesy K, Evans H, O’Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E, Cohen JI. 1989; Expression of Epstein–Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.. New England Journal of Medicine 321:1080–1085
    [Google Scholar]
  33. Zimber-Strobl U, Suentzenich KO, Laux G, Eick D, Cordier M, Calender A, Billaud M, Lenoir G, Bornkamm GW. 1991; Epstein–Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.. Journal of Virology 65:415–423
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-74-7-1393
Loading
/content/journal/jgv/10.1099/0022-1317-74-7-1393
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error